Funder
NHLBI Division of Intramural Research
American Heart Association
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Histology,Pathology and Forensic Medicine
Reference43 articles.
1. Benzoni P, Campostrini G, Landi S, Bertini V, Marchina E, Iascone M, Ahlberg G, Olesen MS, Crescini E, Mora C, Bisleri G, Muneretto C, Ronca R, Presta M, Poliani PL, Piovani G, Verardi R, Di Pasquale E, Consiglio A, Dell’Era P (2019) Human iPSC modelling of a familial form of atrial fibrillation reveals a gain of function of If and ICaL in patient-derived cardiomyocytes. Cardiovasc Res 116(6):1147–1160. https://doi.org/10.1093/cvr/cvz217
2. Bishop WR, Doll R, Kirschmeier P (2011) 15 - Farnesyl Transferase inhibitors: from targeted cancer therapeutic to a potential treatment for progeria. In: Tamanoi F, Hrycyna CA, Bergo MO (eds) The Enzymes, vol 29. Academic Press, pp 275–303
3. Bolderson E, Burgess JT, Li J, Gandhi NS, Boucher D, Croft LV, Beard S, Plowman JJ, Suraweera A, Adams MN, Naqi A, Zhang SD, Sinclair DA, O’Byrne KJ, Richard DJ (2019) Barrier-to-autointegration factor 1 (Banf1) regulates poly [ADP-ribose] polymerase 1 (PARP1) activity following oxidative DNA damage. Nat Commun 10(1):5501. https://doi.org/10.1038/s41467-019-13167-5
4. Bonne G, Barletta MRD, Varnous S, Bécane H-M, Hammouda E-H, Merlini L, Muntoni F, Greenberg CR, Gary F, Urtizberea J-A (1999) Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet 21(3):285–288
5. Brodsky GL, Muntoni F, Miocic S, Sinagra G, Sewry C, Mestroni L (2000) Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 101(5):473–476